ECOR
NASDAQ HealthcareelectroCore, Inc. - Common Stock
Medical Devices
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
�� 市场数据
| 价格 | $9.45 |
|---|---|
| 成交量 | 198,416 |
| 市值 | 78.39M |
| 贝塔系数 | 0.680 |
| RSI（14日） | 70.5 超买 |
| 200日均线 | $5.84 |
| 50日均线 | $6.74 |
| 52周最高 | $10.37 |
| 52周最低 | $4.16 |
| Forward P/E | -17.18 |
| Price / Book | -13.50 |
🎯 投资策略评分
ECOR 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (86/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🐋 Institutional Whale (1/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 ECOR in your text
粘贴任何文章、记录或帖子 — 工具将提取 ECOR 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-06-02.